191 related articles for article (PubMed ID: 21801339)
1. Retinal blood flow in response to an intravitreal injection of ranibizumab for neovascular age-related macular degeneration.
Micieli JA; Tsui E; Lam WC; Brent MH; Devenyi RG; Hudson C
Acta Ophthalmol; 2012 Feb; 90(1):e13-20. PubMed ID: 21801339
[TBL] [Abstract][Full Text] [Related]
2. Long-term results of the effect of intravitreal ranibizumab on the retinal arteriolar diameter in patients with neovascular age-related macular degeneration.
Mendrinos E; Mangioris G; Papadopoulou DN; Donati G; Pournaras CJ
Acta Ophthalmol; 2013 May; 91(3):e184-90. PubMed ID: 23590391
[TBL] [Abstract][Full Text] [Related]
3. Retinal venular caliber predicts visual outcome after intravitreal ranibizumab injection treatments for neovascular AMD.
Wickremasinghe SS; Busija L; Guymer RH; Wong TY; Qureshi S
Invest Ophthalmol Vis Sci; 2012 Jan; 53(1):37-41. PubMed ID: 22110075
[TBL] [Abstract][Full Text] [Related]
4. Intravitreal ranibizumab may induce retinal arteriolar vasoconstriction in patients with neovascular age-related macular degeneration.
Papadopoulou DN; Mendrinos E; Mangioris G; Donati G; Pournaras CJ
Ophthalmology; 2009 Sep; 116(9):1755-61. PubMed ID: 19560206
[TBL] [Abstract][Full Text] [Related]
5. The effect of intravitreal injection of bevacizumab on retinal circulation in patients with neovascular macular degeneration.
Fontaine O; Olivier S; Descovich D; Cordahi G; Vaucher E; Lesk MR
Invest Ophthalmol Vis Sci; 2011 Sep; 52(10):7400-5. PubMed ID: 21693608
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the siRNA PF-04523655 versus ranibizumab for the treatment of neovascular age-related macular degeneration (MONET Study).
Nguyen QD; Schachar RA; Nduaka CI; Sperling M; Klamerus KJ; Chi-Burris K; Yan E; Paggiarino DA; Rosenblatt I; Aitchison R; Erlich SS;
Ophthalmology; 2012 Sep; 119(9):1867-73. PubMed ID: 22683252
[TBL] [Abstract][Full Text] [Related]
7. Incidence of retinal pigment epithelial tears after intravitreal ranibizumab injection for neovascular age-related macular degeneration.
Cunningham ET; Feiner L; Chung C; Tuomi L; Ehrlich JS
Ophthalmology; 2011 Dec; 118(12):2447-52. PubMed ID: 21872935
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of treatment efficacy of intravitreal ranibizumab injections in patients with wet type of AMD.
Lubiński W; Mozolewska-Piotrowska K; Krasodomska K; Penkala K; Kaźmierczak B; Karczewicz D
Klin Oczna; 2012; 114(3):187-93. PubMed ID: 23373399
[TBL] [Abstract][Full Text] [Related]
9. Retinal functional changes measured by microperimetry in neovascular age-related macular degeneration treated with ranibizumab.
Cho HJ; Kim CG; Yoo SJ; Cho SW; Lee DW; Kim JW; Lee JH
Am J Ophthalmol; 2013 Jan; 155(1):118-126.e1. PubMed ID: 23022163
[TBL] [Abstract][Full Text] [Related]
10. Effect of intravitreal bevacizumab on retrobulbar blood flow in injected and uninjected fellow eyes of patients with neovascular age-related macular degeneration.
Hosseini H; Lotfi M; Esfahani MH; Nassiri N; Khalili MR; Razeghinejad MR; Nouri-Mahdavi K
Retina; 2012 May; 32(5):967-71. PubMed ID: 22146127
[TBL] [Abstract][Full Text] [Related]
11. Intravitreal ranibizumab for exudative age-related macular degeneration with good baseline visual acuity.
Saito M; Iida T; Kano M
Retina; 2012 Jul; 32(7):1250-9. PubMed ID: 22446886
[TBL] [Abstract][Full Text] [Related]
12. Determinants of fixation in eyes with neovascular age-related macular degeneration treated with intravitreal ranibizumab.
Mathew R; Pearce E; Sivaprasad S
Am J Ophthalmol; 2012 Mar; 153(3):490-496.e1. PubMed ID: 22071230
[TBL] [Abstract][Full Text] [Related]
13. 24-Gy low-voltage x-ray irradiation with ranibizumab therapy for neovascular AMD: 6-month safety and functional outcomes.
Canton VM; Quiroz-Mercado H; Velez-Montoya R; Lopez-Miranda MJ; Moshfeghi AA; Shusterman EM; Kaiser PK; Sanislo SR; Gertner M; Moshfeghi DM
Ophthalmic Surg Lasers Imaging; 2012; 43(1):20-4. PubMed ID: 22251841
[TBL] [Abstract][Full Text] [Related]
14. Clinical utilization of anti-VEGF agents and disease monitoring in neovascular age-related macular degeneration.
Holekamp NM; Liu Y; Yeh WS; Chia Y; Kiss S; Almony A; Kowalski JW
Am J Ophthalmol; 2014 Apr; 157(4):825-833.e1. PubMed ID: 24388973
[TBL] [Abstract][Full Text] [Related]
15. Response of retinal vessels and retrobulbar hemodynamics to intravitreal anti-VEGF treatment in eyes with branch retinal vein occlusion.
Sacu S; Pemp B; Weigert G; Matt G; Garhofer G; Pruente C; Schmetterer L; Schmidt-Erfurth U
Invest Ophthalmol Vis Sci; 2011 May; 52(6):3046-50. PubMed ID: 21051706
[TBL] [Abstract][Full Text] [Related]
16. Time to first treatment: The significance of early treatment of exudative age-related macular degeneration.
Rauch R; Weingessel B; Maca SM; Vecsei-Marlovits PV
Retina; 2012 Jul; 32(7):1260-4. PubMed ID: 22186738
[TBL] [Abstract][Full Text] [Related]
17. 16 and 24 Gy low-voltage X-ray irradiation with ranibizumab therapy for neovascular age-related macular degeneration: 12-month outcomes.
Morales-Canton V; Quiroz-Mercado H; Velez-Montoya R; Zavala-Ayala A; Moshfeghi AA; Shusterman EM; Kaiser PK; Sanislo SR; Gertner M; Moshfeghi DM
Am J Ophthalmol; 2013 Jun; 155(6):1000-1008.e2. PubMed ID: 23497847
[TBL] [Abstract][Full Text] [Related]
18. The effect of fellow eye visual acuity on visual acuity of study eyes receiving ranibizumab for age-related macular degeneration.
Zweifel SA; Saroj N; Shapiro H; Freund KB
Retina; 2012 Jul; 32(7):1243-9. PubMed ID: 22466461
[TBL] [Abstract][Full Text] [Related]
19. Three-year follow-up of a pilot study of ranibizumab combined with proton beam irradiation as treatment for exudative age-related macular degeneration.
Park SS; Daftari I; Phillips T; Morse LS
Retina; 2012 May; 32(5):956-66. PubMed ID: 22183743
[TBL] [Abstract][Full Text] [Related]
20. Neovascular age-related macular degeneration: intraocular cytokines and growth factors and the influence of therapy with ranibizumab.
Funk M; Karl D; Georgopoulos M; Benesch T; Sacu S; Polak K; Zlabinger GJ; Schmidt-Erfurth U
Ophthalmology; 2009 Dec; 116(12):2393-9. PubMed ID: 19815292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
